Cases

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA MARK MCAFEE, et al., : : Plaintiffs, : Civil Action No.: 19-3161 (RC) : v. : Re Document Nos.: 15, 17

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA MELINTA THERAPEUTICS, LLC, et. al, : : Plaintiffs, : Civil Action No.: 22-2190 (RC) : v. : Re Document No.: 5, 6 : U.S. FOOD & D

751 F.Supp. 243 (1990) Douglas L. TEICH, M.D., Plaintiff, v. FOOD AND DRUG ADMINISTRATION, et al., Defendants, and Dow Corning Corporation, Intervenor-Defendant and Cross-Claim Defendant. Civ. A. No. 89-0391. United States District Court, District of Columbia. November 27, 1990. *244 *245

Amit P. Mehta, United States District Judge I. INTRODUCTION On May 10, 2016, the U.S. Food and Drug Administration ("FDA") published a final rule "deeming" cigars, pipe tobacco, and certain other products (e.g., e-cigarettes) subject to the federal Food, Drug, and Cosmetic Act ("FD & C Act"),

MEMORANDUM OPINION AMY BERMAN JACKSON, United States District Judge An electronic cigarette, or “e-cigarette,” is an electronic nicotine delivery device, comprised of a liquid, an atomizer or heating element that heats the liquid to create a vapor, and a battery that powers the heating element. Most liquids on the market contain nicotine.

MEMORANDUM OPINION RICHARD J. LEON, District Judge. Plaintiffs, a group of death row inmates currently incarcerated in Arizona, California, and Tennessee, bring this action against the Food and Drug Administration (“FDA”), the United States Department of Health and Human Services (“HHS”), Kathleen Sebelius in her official capacity as Secretary

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) CIGAR ASSOCIATION OF AMERICA, et al., ) ) Plaintiffs, ) ) v. ) Case No. 1:16-cv-01460 (APM)

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) CIGAR ASSOCIATION OF AMERICA, et al., ) ) Plaintiffs, ) ) v. ) Case No. 1:16-cv-01460 (APM)

OPINION & ORDER PAUL A. ENGELMAYER, District Judge: In United States v. Caronia, 703 F.3d 149 (2d Cir.2012), the Court of Appeals for the Second Circuit vacated a pharmaceutical sales representative’s conviction for conspiring to introduce a misbranded drug into interstate commerce, in violation of 21 U.S.C. §§ 331(a) and 333(a)(1). The conviction was based" on Caronia’s havi

MEMORANDUM OPINION AND ORDER Amit P. Mehta, United States District Judge I. INTRODUCTION Plaintiffs are a group of tobacco companies 1 who seek my recusal in this case primarily because my former law partner provided legal services to an anti-tobacco organization — the Campa

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA _________________________________________ ) Philip Morris USA Inc., et al., ) ) Plaintiffs, ) ) v. ) Civil No. 1:15-cv-01590 (APM)

Opinion for the Court filed by Senior Circuit Judge WILLIAMS. WILLIAMS, Senior Circuit Judge: With the Family Smoking Prevention and Tobacco Control Act of 2009, Pub.L. No. 111-31, § 101 (2009), Congress directed the Food and Drug Administration to establish a twelve-member Tobacco Products Scientific Advisory Committee, the duties of which included repor

Opinion for the Court filed PER CURIAM. On Motion for Summary Affirmance PER CURIAM. This case is the latest flare-up in a long-running dispute between the Food and Drug Administration (FDA) and several generic drug manufacturers as to what qualifies under the Hatch-Waxman Act as “a decision of a court ... holding [a challeng

(Slip Opinion) Whether the Food and Drug Administration Has Jurisdiction over Articles Intended for Use in Lawful Executions May 3, 2019 Articles intended for use in executions carried out by a State or the federal government cannot be regulated as “drugs” or “devices” under the Federal Food, Drug, and Cos- metic Act. The Food and Drug Administration therefore lacks juri

MEMORANDUM OPINION AND ORDER THEODORE H. KATZ, United States Magistrate Judge. Plaintiffs Natural Resources Defense Council, Inc. (“NRDC”), Center for Science in the Public Interest, Food Animal Concerns Trust, Public Citizen, and Union of Concerned Scientists, Inc. (collectively “Plaintiffs”) bring this action against the United States Food and Drug Administration (“FDA”), Margaret Hamburg, in her offici

Opinion for the Court filed by Circuit Judge RANDOLPH. *2 RANDOLPH, Circuit Judge: The Federal Food, Drug, and Cosmetic Act grants a 180-day exclusive marketing period to the first generic drug manufacturer to file an Abbreviated New Drug Application (“application”) that contains a cha

SACK, Circuit Judge: The plaintiffs are wholesale dealers in pharmaceutical products including Adde-rall XR, a widely prescribed drug manufactured by the defendants. They brought this putative class action alleging that the defendants violated the anti-monopolization provision of the Sherman Act by breaching defendants’ contracts to supply two of their competitors—who in turn supp

Judgment rendered August 28, 2024. Application for rehearing may be filed within the delay allowed by Art. 2166, La. C.C.P. No. 55,933-JAC COURT OF APPEAL SECOND CIRCUIT STATE OF LOUISIANA *****

13–1232 Louisiana Wholesale Drug Co. v. Shire LLC UNITED STATES COURT OF APPEALS FOR THE SECOND CIRCUIT August Term, 2013 (Argued: March 17, 2014 Decided: June 9, 2014) Docket No. 13–1232 In re ADDERALL XR ANTITRUST LITIGATION

DECISION AND ORDER VICTOR MARRERO, District Judge. Plaintiff Louisiana Wholesale Drug Company, Inc. (“LWD”), on behalf of itself and all others similarly situated, brought this action against Shire LLC and Shire U.S., Inc. (collectively, “Shire” or “Defendants”), asserting a violation of 15 U.S.C. § 2. Shire filed a motion to dismiss the complaint for failure to state a claim upon which relief